Megakaryocyte: Difference between revisions
CSV import |
CSV import |
||
| Line 20: | Line 20: | ||
{{stub}} | {{stub}} | ||
== Megakaryocyte == | |||
<gallery> | |||
File:WVSOM_Megakaryocytes_arrows.jpg|WVSOM Megakaryocytes with arrows | |||
File:Illu_blood_cell_lineage.jpg|Illustration of blood cell lineage | |||
File:Platelets_release_in_mature_megakaryocytes_.gif|Platelets release in mature megakaryocytes | |||
</gallery> | |||
Latest revision as of 21:10, 23 February 2025
Megakaryocyte is a large bone marrow cell with a lobulated nucleus responsible for the production of blood thrombocytes (platelets), which are necessary for normal blood clotting. Megakaryocytes usually account for 1 out of 10,000 bone marrow cells but can increase in number nearly 10-fold during the process of thrombopoiesis. They are derived from hematopoietic stem cells in the bone marrow.
Structure[edit]
Megakaryocytes are 10 to 15 times larger than a typical red blood cell. They have a large, lobulated nucleus, violet granules in their cytoplasm, and demarcation membranes which outline platelet territories.
Function[edit]
The main function of the megakaryocyte is to produce platelets. This process is regulated by the hormone thrombopoietin. Megakaryocytes also contribute to homeostasis by producing a variety of substances that can promote inflammation and wound healing.
Clinical significance[edit]
Abnormalities in the number or function of megakaryocytes can lead to a variety of diseases. For example, a decrease in the number of megakaryocytes can lead to thrombocytopenia, a condition characterized by low platelet count. Conversely, an increase in the number of megakaryocytes can lead to thrombocytosis, a condition characterized by a high platelet count.


